Actually that was the only graphic not about mortality, but all acute repiratory diseases by all pathogens combined, up to 22nd of March. Therefore can't tell anything about excess mortality - as the graphics before that did - but the incidence of acute respiratory diseases this year, compared to the last 3 years.
Dr Raoult Team noticed something similar in South France!
Here a blue print published online two days ago from IHU Marseille
Decreased mortality associated with respiratory viral infections between December 2019 and March 2020 compared to previous year, South east France
Author list: Audrey GIRAUD-GATINEAU1,2,3 § , Philippe COLSON1,4 §, Marie-Thérèse
JIMENO5, Christine ZANDOTTI1, Laetitia NINOVE1,6, Céline BOSCHI1,4, Jean-
Christophe LAGIER1,4, Bernard LA SCOLA1,4, Hervé CHAUDET1,2,3, Didier
RAOULT1,4*
...
The University Hospital Institute Méditerranée Infection performs real-time
surveillance of all infections diagnosed in public hospitals of Marseille, Southeastern France
3;4. This includes the count of the deaths associated with any diagnosed infection. Here, we
compared the mortality associated with diagnoses of respiratory viruses during colder months
overlapping 2018-2019 and 2019-2020.
......... Between week 47 of 2018 and week 11 of 2019, 72 patients
died after being diagnosed with a respiratory virus (Table 1). They represented 0.16% of the
43,909 patients hospitalized during this period and 6.9% of the 1,042 who died. Deaths
occurred in 38 of the patients diagnosed with Influenza A virus (1.7%), which was the
respiratory virus associated with the highest number of deaths. In addition, deaths occurred in
19 of the patients diagnosed with rhinoviruses (1.8%), and in 13 of those diagnosed with
respiratory syncytial virus (RSV) (1.1%). Respiratory samples had not been tested for
coronaviruses and parainfluenza viruses in routine clinical practice, but all those tested
retrospectively from dead patients were negative. In comparison, during the same period of
3 winter 2019-2020 (between week 47 of 2019 and week 11 of 2020), 44 patients died after
being diagnosed with a common respiratory virus. They represented 0.11% of the 52,624
patients hospitalized during this period and 5.6% of the 985 who died. They included 6 of the
patients diagnosed with influenza A virus (0.4%), 2 of those diagnosed with influenza B virus
(0.2%), 7 of those diagnosed with RSV (0.7%), and 4, 2 and 1 of those diagnosed with human
coronavirus-HKU1 (1.7%), NL63 (1.2%) and OC43 (1.0%), respectively (Table 1).
Additionally, we tested since the 29th of January 13,089 patients for SARS-CoV-2 using a
reverse transcription-PCR assay 5, and diagnosed 1,416 infections (11%). Of these infected
patients, 11 (0.8%) died; 8 were 82 year-old and 5 were men.
Overall, 55 patients died after being diagnosed with a respiratory virus during colder months of 2019-2020 so far, versus 72 the year before.
The proportion of respiratory virus-associated deaths among hospitalized
patients was thus significantly lower in 2019-2020 than in 2018-2019 (105 per 100,000
people vs 164 per 100,000 people; p= 0.007, Yates-corrected chi-square test). This proportion
among patients who died of any cause at hospital was also lower, although not significantly;
Hence, we observed 39% less deaths associated with common respiratory viruses
during colder months of 2019-2020 compared to 2018-2019.
This was essentially due to
significant decreases of influenza A virus (-84%; p<10-3) and RSV (-46%; p=0.055)-
associated deaths, and was not compensated so far by SARS-CoV-2-related deaths. Excess
mortality associated with influenza virus infections is estimated to be 5.9 per 100,000 people
worldwide and 5.3 per 100,000 people in Europe 6. In comparison, mean mortality associated
with SARS-CoV-2 infections is estimated to be 0.3 per 100,000 people worldwide and 2.2 per
100,000 people in Western Europe (
https://www.mediterranee-infection.com/covid-19/).
These data and our findings allow putting into perspective the death burden of SARS-CoV-2
infections….